… insight into the structural features required for activity to predict more potent and selective
chemical entities acting as EGFR inhibitors of the Panc-1 human pancreas cancer cell line. …

… EGFR inhibitors have been screened against the EGFR … docked compounds in the active
pocket of EGFR (C), and closed view of docked compounds in the active pocket of EGFR …

… A high-throughput docking was performed using the mutated EGFR–EAI045 complex, a
L858R/T790M mutant EGFR, and a homology model of EGFR, which produced 92 small …

… provide very useful information and insights for both basic research … docking approach to
investigate the binding mechanism of EGFR with its ligands in hopes to provide useful insights …

… EGFR inhibitors was their affinity to bind with wild type EGFR. This … selective inhibition against
drug-resistant mutant EGFR … EGFR inhibitors which have selectivity for oncogenic mutant …

… only drug capable of overcoming EGFR-T790M-mutated NSCLC until date. Subsequently,
we launched a docking-based virtual screening campaign against the EGFR kinase with the …

… are in agreement with the expected outcome of EGFR inhibition. Finally, the molecular docking
of 7g and 7m in the active site of EGFR revealed a common binding pattern similar to that …

… Docking-Based Virtual Screening In this study, protein-ligand docking was performed using
the crystal structure of EGFR (… For docking validation, the crystalized ligand was defined as a …

… and validate the results for both wild-type and mutant EGFR, we conducted self-docking
of the bound reference ligands with their respective proteins (compound 41a with wild-type …

… docking studies of pyrimidine compounds. We have added the comparative docking
analysis followed by the molecular simulation study against the four different PDBs of EGFR to …